Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection
Authors
Keywords
-
Journal
NANO LETTERS
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-03-09
DOI
10.1021/acs.nanolett.0c04687
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel Epstein‐Barr virus subtype associated with nasopharyngeal carcinoma found in South China
- (2020) Lawrence S. Young Cancer Communications
- Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
- (2019) Wei Bu et al. IMMUNITY
- Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
- (2019) Rui-Mei Feng et al. Cancer Communications
- Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model
- (2018) Bingchun Zhao et al. Frontiers in Immunology
- Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
- (2018) Talar Tokatlian et al. SCIENCE
- Structure and assembly of scalable porous protein cages
- (2017) Eita Sasaki et al. Nature Communications
- Design of a hyperstable 60-subunit protein icosahedron
- (2016) Yang Hsia et al. NATURE
- Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
- (2016) Linling He et al. Nature Communications
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
- (2015) Javier Ogembo et al. Journal of Translational Medicine
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
- (2013) J. Jardine et al. SCIENCE
- A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine
- (2013) Xinle Cui et al. VACCINE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas
- (2013) Ming-Han Tsai et al. Cell Reports
- Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
- (2013) Javier G. Ogembo et al. Cell Reports
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Directed Evolution of a Protein Container
- (2011) B. Worsdorfer et al. SCIENCE
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started